Close
More
 
 

Join Now

It's Free - Always

First Name
 
Last Name
 
Zip/Postal Code
 
Country of Practice
 
 
 
Specialty
Email
 
Password
 
Confirm Password
 
Terms
I have read and agree to the Participant Terms and Conditions
 
 
 

is already registered on QuantiaMD

Is this you? Enter your password to continue.
The password you entered is incorrect. Please try again or choose a different option.
Forgot your password? Click here and password reset instructions will be sent to the above email address.
Need more help? Contact Member Support
 
 

is already registered on QuantiaMD

 
 
Instructions to reset your password have been sent to the following email address:

For further assistance, please Contact Member Support
Thank you for registering on QuantiaMD.

Forgot your password?

Please enter your email address below, and we will send you a link to reset your password.

Submit
Earn this Certificate
0%
0 out of 5 completed
Medical Management of Diabetes: A 2016 Update

Your patient is one of the majority of US patients with diabetes who are not able to achieve their target A1c goals. What do you do? Dr. Neil Skolnik and colleagues offer an overview of your treatment options with an emphasis on newer medications for diabetes. They will discuss barriers to achieving A1c goals, criteria for individualizing treatment for each patient, and how to decide which medication to choose next when your patients are not reaching their target. They will address the ADA’s evaluation of several drug classes’ efficacy, hypoglycemia risk, weight considerations, side effects, and cost, so that you are armed with a comprehensive understanding of how to best treat each of your patients.

Neil Skolnik, MD
Professor of Family and Community Medicine, Temple University School of Medicine, Associate Director, Family Medicine Residency Program, Abington Jefferson Health
Start the next presentation
You've completed 0 out of 5 presentations
 
Expert Presentations
Neil Skolnik, MD
Professor of Family and Community Medicine, Temple University School of Medicine, Associate Director, Family Medicine Residency Program, Abington Jefferson Health
(54)
7 Comments, last 5 days ago
Andrew S. Rhinehart, MD, FACP, FACE, CDE, BC-ADM, CDTC
Chief Medical Officer, Glytec
(40)
3 Comments
Eric Johnson, MD
Associate Professor, University of North Dakota School of Medicine and Health Sciences, Assistant Medical Director, Altru Diabetes Center, Grand Forks, ND
(318)
144 Comments, last 19 days ago
Jay H. Shubrook, DO, FACOFP, FAAFP
Professor, Touro University California College of Osteopathic Medicine, Vallejo, CA
(28)
2 Comments
Jim Chamberlain, MD
Medical Director for Diabetes Services, St. Mark’s Hospital and St. Mark’s Diabetes Center, Salt Lake City, Utah
(198)
138 Comments, last 2 days ago
Latest Comments
"The lawsuits are related to DKA which is occurring almost exclusively in type 1 diabetes for which these drugs are not approved!"
Jim Chamberlain, MD
Medical Director for Diabetes Services, St. Mark’s Hospital and St. Mark’s Diabetes Center, Salt Lake City, Utah
138 Comments, last 2 days ago
"Excellent speaker!  Covered information in a very clear manner.  Thank you."
Liane Fujita, APRN-CNS
The Queen’s Medical Center
7 Comments, last 5 days ago
 
Terms | Privacy | FAQ | support@quantiamd.com | 1-800-773-4162
©2016 Quantia, a wholly owned subsidiary of Aptus Health, Inc.
 
Version 2.13.40.12